Position in JAZZ
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$358,290,394
-$87,671,116 QoQ
Shares Held
1,895,215
-27.8% QoQ
Ownership
2.92%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92%
Shared 6%
None 2%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $4,772,684,897 across 224 Biotechnology names. JAZZ ranks #3 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in JAZZ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $358,290,394 | 1,895,215 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $445,961,510 | 2,623,303 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $373,870,732 | 2,836,652 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $269,315,259 | 2,537,837 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $289,074,583 | 2,328,430 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $250,618,869 | 2,035,070 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $190,995,285 | 1,714,346 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $130,445,189 | 1,222,198 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $99,183,810 | 823,649 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $94,199,058 | 765,846 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $102,984,016 | 795,612 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $101,893,793 | 821,923 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $122,917,636 | 840,003 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $133,431,998 | 837,562 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $126,997,376 | 952,790 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $156,695,038 | 1,004,391 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $157,132,986 | 1,009,398 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $126,910,911 | 996,161 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $122,803,134 | 943,116 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $158,842,135 | 894,180 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $147,697,622 | 898,568 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $146,018,084 | 884,690 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $126,765,219 | 889,019 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $101,979,979 | 924,234 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $95,940,105 | 961,902 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||